Genhai Shen

702 total citations
15 papers, 334 citations indexed

About

Genhai Shen is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Genhai Shen has authored 15 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Genhai Shen's work include Cancer Mechanisms and Therapy (4 papers), Autophagy in Disease and Therapy (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Genhai Shen is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Autophagy in Disease and Therapy (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Genhai Shen collaborates with scholars based in China, United States and Japan. Genhai Shen's co-authors include Quangen Gao, Guoliang Wu, Jianping Qiu, Gang Wang, Wei Dai, Zheng‐Hong Qin, Bin Li, Liqiang Qian, Zheng Wang and Yan Liu and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Medicine.

In The Last Decade

Genhai Shen

15 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Genhai Shen China 10 202 84 60 58 36 15 334
Nianping Chen China 12 284 1.4× 96 1.1× 54 0.9× 79 1.4× 42 1.2× 18 457
Wenxiang Shen China 9 240 1.2× 57 0.7× 52 0.9× 106 1.8× 34 0.9× 17 396
Gabrielle Gossner United States 10 177 0.9× 70 0.8× 60 1.0× 58 1.0× 62 1.7× 14 389
Heqi Bu China 13 275 1.4× 72 0.9× 73 1.2× 78 1.3× 38 1.1× 18 453
Chia‐Yao Shen Taiwan 12 218 1.1× 68 0.8× 47 0.8× 47 0.8× 25 0.7× 18 412
Mi‐Hyeon Jeong South Korea 13 264 1.3× 65 0.8× 34 0.6× 78 1.3× 36 1.0× 18 400
Xiaoyang Huang China 11 203 1.0× 55 0.7× 47 0.8× 38 0.7× 28 0.8× 14 388
Sebastiano Andò Italy 6 287 1.4× 118 1.4× 80 1.3× 101 1.7× 70 1.9× 7 495

Countries citing papers authored by Genhai Shen

Since Specialization
Citations

This map shows the geographic impact of Genhai Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genhai Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genhai Shen more than expected).

Fields of papers citing papers by Genhai Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genhai Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genhai Shen. The network helps show where Genhai Shen may publish in the future.

Co-authorship network of co-authors of Genhai Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Genhai Shen. A scholar is included among the top collaborators of Genhai Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genhai Shen. Genhai Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Zhang, Lu, Lei Peng, Shumin Yang, et al.. (2025). Cabozantinib selectively induces proteasomal degradation of p53 somatic mutant Y220C and impedes tumor growth. Journal of Biological Chemistry. 301(2). 108167–108167. 1 indexed citations
3.
Wu, Jian, et al.. (2025). CD39 Contributes to the Ability of Cell Invasion in Heterogeneity of Colorectal Cancer. Journal of Cellular and Molecular Medicine. 29(5). e70486–e70486. 1 indexed citations
4.
Qian, Liqiang, et al.. (2020). Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder Cancer. Journal of Cancer. 11(11). 3114–3123. 35 indexed citations
5.
Zhang, Zhi, Gang Wang, Jie Qiu, et al.. (2019). Laparoscopic diagnosis and extraction of an ingested fish bone that penetrated the stomach. Medicine. 98(50). e18373–e18373. 3 indexed citations
6.
Li, Bin, Guoliang Wu, Wei Dai, et al.. (2018). Aescin-induced reactive oxygen species play a pro-survival role in human cancer cells via ATM/AMPK/ULK1-mediated autophagy. Acta Pharmacologica Sinica. 39(12). 1874–1884. 24 indexed citations
7.
Wu, Jian, Tetsu Fukunaga, Oka S, et al.. (2018). Comparative study of outcomes of Roux-en-Y reconstruction and Billroth Ⅰ reconstruction performed after radical distal gastrectomy. Asian Journal of Surgery. 42(1). 379–385. 3 indexed citations
8.
Li, Bin, Zhong Wang, Jiaming Xie, et al.. (2018). TIGAR knockdown enhanced the anticancer effect of aescin via regulating autophagy and apoptosis in colorectal cancer cells. Acta Pharmacologica Sinica. 40(1). 111–121. 21 indexed citations
9.
10.
Wang, Gang, et al.. (2017). Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway. Cytotechnology. 70(1). 83–94. 20 indexed citations
11.
Li, Bin, Junjie Guan, Haidong Xu, et al.. (2017). Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells. Acta Pharmacologica Sinica. 38(9). 1305–1316. 47 indexed citations
12.
13.
Wang, Zhong, Genhai Shen, Jiaming Xie, Bin Li, & Quangen Gao. (2017). Rottlerin upregulates DDX3 expression in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 495(1). 1503–1509. 17 indexed citations
14.
Liu, Yan, Tingting Bi, Zheng Wang, et al.. (2016). Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway. APOPTOSIS. 21(12). 1398–1407. 54 indexed citations
15.
Dai, Wei, et al.. (2015). Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma. Tumor Biology. 37(5). 6307–6313. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nianping Chen Breakdown of academic impact, for papers by Wenxiang Shen Breakdown of academic impact, for papers by Gabrielle Gossner Breakdown of academic impact, for papers by Heqi Bu Breakdown of academic impact, for papers by Chia‐Yao Shen Breakdown of academic impact, for papers by Mi‐Hyeon Jeong Breakdown of academic impact, for papers by Xiaoyang Huang Breakdown of academic impact, for papers by Sebastiano Andò
Rankless by CCL
2026